Tekla Life Sciences Investors

HQLNYSEFinancial Services● Active

$16.91

$-0.01(-0.07%)

Market Cap$514165831

P/E Ratio—

52W High$18.46

52W Low$12.34

Avg Volume105K

Open$17.07

Beta0.73

Overview

Tekla Life Sciences Investors (HQL) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

HQL · cash on hand · updated Sep 30, 2025

Core cash position

as of Sep 30, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$75,538

FY · as of Sep 30, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$75,538

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

—

vs prior fiscal year

Latest Quarter

$75,538

Q3 2025

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: September 30, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$75,538Cash on Hand

Total Debt$0Total Debt

Net Cash / Net Debt+$75,538Net Cash Position

Cash vs Debt Ratio

Cash 100%Tekla Life Sciences Investors cash as % of market cap: 0.01%% · MCap $1BDebt 0%

Tekla Life Sciences Investors has a net cash position of $75,538, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$75,538 − $0 = +$75,538

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

HQL annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

HQL cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Sep 30, 2025LatestFY$0.1M—

Sep 30, 2024FY$0.0M-100.0%

Sep 30, 2023FY$15.2M+3425175.7%

Sep 30, 2022FY$0.0M-55.1%

Sep 30, 2021FY$0.0M-100.0%

HQL cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Financial Services Sector Cash Reserves Comparison

HQL vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

Berkshire Hathaway Inc.

Mastercard Incorporated

$10.90B$430B2.5%

Tekla Life Sciences InvestorsYOU

HQL

$0.1M$513M0.0%

Financial Services sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Tekla Life Sciences Investors (HQL) cash on hand as of September 30, 2025 is $75,538, comprising $75,538 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Tekla Life Sciences Investors cash and short-term investments on the balance sheet (10-K filing). Also referred to as Tekla Life Sciences Investors cash reserves or cash position.

Tekla Life Sciences Investors annual cash on hand history shows decreased — in 2025: decreased — in 2025. Tekla Life Sciences Investors cash reserves in 2025 reflect the company's capital allocation strategy.

Tekla Life Sciences Investors carries total debt of $0 against cash of $75,538, resulting in a net cash position of +$75,538. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

HQL cash on hand · 5 questions

As of September 30, 2025, Tekla Life Sciences Investors (HQL) has $75,538 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $75,538 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (September 30, 2025): $75,538. Data sourced from the annual 10-K filing via FMP.

HQL cash on handHQL cash reservesHQL cash 2025how much cash does HQL have

▸ Source: FMP /balance-sheet-statement · US GAAP · Tekla Life Sciences Investors · Tekla Life Sciences Investors SEC 10-K & 10-Q filings · US GAAP · Last updated: September 30, 2025